Literature DB >> 21788343

Cilengitide induces autophagy-mediated cell death in glioma cells.

Stephanie L Lomonaco1, Susan Finniss, Cunli Xiang, Hae Kyung Lee, Wei Jiang, Nancy Lemke, Sandra A Rempel, Tom Mikkelsen, Chaya Brodie.   

Abstract

We studied the effect of the integrin inhibitor cilengitide in glioma cells. Cilengitide induced cell detachment and decreased cell viability, and induction of autophagy followed by cell apoptosis. In addition, cilengitide decreased the cell renewal of glioma stem-like cells (GSCs). Inhibition of autophagy decreased the cytotoxic effect of cilengitide. Pretreatment of glioma cells and GSCs with cilengitide prior to γ-irradiation resulted in a larger increase in autophagy and a more significant decrease in cell survival. We found that cilengitide induced autophagy collectively in glioma cells, xenografts, and GSCs, which contributed to its cytotoxic effects and sensitized these cells to γ-radiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21788343      PMCID: PMC3145473          DOI: 10.1093/neuonc/nor073

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  42 in total

Review 1.  Life and death partners: apoptosis, autophagy and the cross-talk between them.

Authors:  A Eisenberg-Lerner; S Bialik; H-U Simon; A Kimchi
Journal:  Cell Death Differ       Date:  2009-03-27       Impact factor: 15.828

Review 2.  Lethal weapons: DAP-kinase, autophagy and cell death: DAP-kinase regulates autophagy.

Authors:  Shani Bialik; Adi Kimchi
Journal:  Curr Opin Cell Biol       Date:  2009-12-11       Impact factor: 8.382

Review 3.  Integrins in cancer: biological implications and therapeutic opportunities.

Authors:  Jay S Desgrosellier; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

Review 4.  Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer.

Authors:  Kevin N Dalby; Ibrahim Tekedereli; Gabriel Lopez-Berestein; Bulent Ozpolat
Journal:  Autophagy       Date:  2010-04-26       Impact factor: 16.016

Review 5.  Targeting integrins in malignant glioma.

Authors:  Ghazaleh Tabatabai; Michael Weller; Burt Nabors; Martin Picard; David Reardon; Tom Mikkelsen; Curzio Ruegg; Roger Stupp
Journal:  Target Oncol       Date:  2010-09-04       Impact factor: 4.493

Review 6.  Brain cancer propagating cells: biology, genetics and targeted therapies.

Authors:  Costas G Hadjipanayis; Erwin G Van Meir
Journal:  Trends Mol Med       Date:  2009-11-02       Impact factor: 11.951

7.  Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells.

Authors:  María Salazar; Arkaitz Carracedo; Iñigo J Salanueva; Sonia Hernández-Tiedra; Mar Lorente; Ainara Egia; Patricia Vázquez; Cristina Blázquez; Sofía Torres; Stephane García; Jonathan Nowak; Gian María Fimia; Mauro Piacentini; Francesco Cecconi; Pier Paolo Pandolfi; Luis González-Feria; Juan L Iovanna; Manuel Guzmán; Patricia Boya; Guillermo Velasco
Journal:  J Clin Invest       Date:  2009-05       Impact factor: 14.808

8.  Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro.

Authors:  Gabriele D Maurer; Isabel Tritschler; Barbara Adams; Ghazaleh Tabatabai; Wolfgang Wick; Roger Stupp; Michael Weller
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

Review 9.  Regulation mechanisms and signaling pathways of autophagy.

Authors:  Congcong He; Daniel J Klionsky
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

10.  The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells.

Authors:  Stephanie L Lomonaco; Susan Finniss; Cunli Xiang; Ana Decarvalho; Felix Umansky; Steven N Kalkanis; Tom Mikkelsen; Chaya Brodie
Journal:  Int J Cancer       Date:  2009-08-01       Impact factor: 7.396

View more
  20 in total

1.  End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma.

Authors:  Warren P Mason
Journal:  Neuro Oncol       Date:  2015-02-13       Impact factor: 12.300

2.  Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: a report from the Children's Oncology Group.

Authors:  Tobey J MacDonald; Gilbert Vezina; Clinton F Stewart; David Turner; Christopher R Pierson; Lu Chen; Ian F Pollack; Amar Gajjar; Mark W Kieran
Journal:  Neuro Oncol       Date:  2013-09-05       Impact factor: 12.300

3.  The effect of cilengitide in combination with irradiation and chemotherapy in head and neck squamous cell carcinoma cell lines.

Authors:  G Heiduschka; C Lill; S Schneider; R Seemann; G Kornek; R Schmid; U Kotowski; D Thurnher
Journal:  Strahlenther Onkol       Date:  2014-02-21       Impact factor: 3.621

4.  Acute Temporal Changes of MRI-Tracked Tumor Vascular Parameters after Combined Anti-angiogenic and Radiation Treatments in a Rat Glioma Model: Identifying Signatures of Synergism.

Authors:  Rasha Elmghirbi; Tavarekere N Nagaraja; Stephen L Brown; Swayamprava Panda; Madhava P Aryal; Kelly A Keenan; Hassan Bagher-Ebadian; Glauber Cabral; James R Ewing
Journal:  Radiat Res       Date:  2016-12-21       Impact factor: 2.841

5.  TRAIL conjugated to nanoparticles exhibits increased anti-tumor activities in glioma cells and glioma stem cells in vitro and in vivo.

Authors:  Benny Perlstein; Susan A Finniss; Cathie Miller; Hana Okhrimenko; Gila Kazimirsky; Simona Cazacu; Hae Kyung Lee; Nancy Lemke; Shlomit Brodie; Felix Umansky; Sandra A Rempel; Mark Rosenblum; Tom Mikklesen; Shlomo Margel; Chaya Brodie
Journal:  Neuro Oncol       Date:  2012-11-08       Impact factor: 12.300

Review 6.  Brain tumor stem cells: Molecular characteristics and their impact on therapy.

Authors:  David L Schonberg; Daniel Lubelski; Tyler E Miller; Jeremy N Rich
Journal:  Mol Aspects Med       Date:  2013-07-04

7.  Suppression of autophagy enhanced growth inhibition and apoptosis of interferon-β in human glioma cells.

Authors:  Yubin Li; Haiyan Zhu; Xian Zeng; Jiajun Fan; Xiaolu Qian; Shaofei Wang; Ziyu Wang; Yun Sun; Xiaodan Wang; Weiwu Wang; Dianwen Ju
Journal:  Mol Neurobiol       Date:  2013-01-18       Impact factor: 5.590

8.  Molecular interactions of ErbB1 (EGFR) and integrin-β1 in astrocytoma frozen sections predict clinical outcome and correlate with Akt-mediated in vitro radioresistance.

Authors:  Miklós Petrás; Tamás Lajtos; Elza Friedländer; Almos Klekner; Eva Pintye; Burt G Feuerstein; János Szöllosi; György Vereb
Journal:  Neuro Oncol       Date:  2013-04-17       Impact factor: 12.300

9.  Functional analysis of a novel glioma antigen, EFTUD1.

Authors:  Katsuya Saito; Yukihiko Iizuka; Shigeki Ohta; Satoshi Takahashi; Kenta Nakamura; Hideyuki Saya; Kazunari Yoshida; Yutaka Kawakami; Masahiro Toda
Journal:  Neuro Oncol       Date:  2014-07-11       Impact factor: 12.300

Review 10.  Every step of the way: integrins in cancer progression and metastasis.

Authors:  Hellyeh Hamidi; Johanna Ivaska
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.